- Home
- PCRX vs MHD Comparison
PCRX vs MHD Comparison
Compare PCRX & MHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- MHD
- Stock Information
- Founded
- PCRX 2006
- MHD N/A
- Country
- PCRX United States
- MHD United States
- Employees
- PCRX N/A
- MHD N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- MHD Investment Bankers/Brokers/Service
- Sector
- PCRX Health Care
- MHD Finance
- Exchange
- PCRX Nasdaq
- MHD Nasdaq
- Market Cap
- PCRX 1.2B
- MHD 592.9M
- IPO Year
- PCRX 2011
- MHD N/A
- Fundamental
- Price
- PCRX $22.90
- MHD $11.20
- Analyst Decision
- PCRX Buy
- MHD
- Analyst Count
- PCRX 8
- MHD 0
- Target Price
- PCRX $28.38
- MHD N/A
- AVG Volume (30 Days)
- PCRX 525.8K
- MHD 124.9K
- Earning Date
- PCRX 07-29-2025
- MHD 01-01-0001
- Dividend Yield
- PCRX N/A
- MHD 4.16%
- EPS Growth
- PCRX N/A
- MHD N/A
- EPS
- PCRX N/A
- MHD N/A
- Revenue
- PCRX $702,772,000.00
- MHD N/A
- Revenue This Year
- PCRX $7.92
- MHD N/A
- Revenue Next Year
- PCRX $11.02
- MHD N/A
- P/E Ratio
- PCRX N/A
- MHD N/A
- Revenue Growth
- PCRX 3.08
- MHD N/A
- 52 Week Low
- PCRX $11.16
- MHD $9.92
- 52 Week High
- PCRX $27.64
- MHD $12.18
- Technical
- Relative Strength Index (RSI)
- PCRX 35.82
- MHD 49.91
- Support Level
- PCRX $22.82
- MHD $11.13
- Resistance Level
- PCRX $23.83
- MHD $11.25
- Average True Range (ATR)
- PCRX 0.74
- MHD 0.07
- MACD
- PCRX -0.02
- MHD 0.01
- Stochastic Oscillator
- PCRX 6.22
- MHD 54.17
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About MHD Blackrock MuniHoldings Fund Inc.
Blackrock Muniholdings Fund Inc is a closed-end management investment company. The fund's objective is to provide shareholders with current income exempt from U.S. federal income taxes. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.